525.72
Schlusskurs vom Vortag:
$547.54
Offen:
$540.1
24-Stunden-Volumen:
30.19M
Relative Volume:
2.06
Marktkapitalisierung:
$1.33T
Einnahmen:
$200.97B
Nettoeinkommen (Verlust:
$60.46B
KGV:
22.38
EPS:
23.4909
Netto-Cashflow:
$46.11B
1W Leistung:
-11.44%
1M Leistung:
-18.89%
6M Leistung:
-29.31%
1J Leistung:
-12.76%
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
525.72 | 1.33T | 200.97B | 60.46B | 46.11B | 23.49 |
|
GOOGL
Alphabet Inc
|
274.34 | 3.32T | 403.06B | 132.17B | 73.27B | 10.81 |
|
GOOG
Alphabet Inc
|
273.76 | 3.31T | 403.06B | 132.17B | 73.27B | 10.81 |
|
SPOT
Spotify Technology S A
|
472.48 | 97.28B | 19.43B | 2.56B | 3.41B | 9.6489 |
|
DASH
Doordash Inc
|
146.60 | 63.69B | 13.72B | 932.00M | 1.83B | 2.1265 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Prediction: These 2 Stocks Will Be Worth More Than Apple in a Decade - The Motley Fool
Meta and Google’s addiction verdict exposes big tech’s accountability glitch - Taipei Times
Meta Platforms Just Cut Jobs. Does That Make META Stock a Buy, Sell, or Hold Before Q2 Starts? - Yahoo Finance
Leaked Meta memo reveals company’s bizarre plan after layoffs - thestreet.com
Meta: I'm More Than Willing To Catch The Falling Knife Now (NASDAQ:META) - Seeking Alpha
How the landmark verdict against Meta and YouTube could hit their businesses - Los Angeles Times
Quantum Financial Advisors LLC Raises Holdings in Meta Platforms, Inc. $META - MarketBeat
DAVENPORT & Co LLC Sells 66,991 Shares of Meta Platforms, Inc. $META - MarketBeat
E. Ohman J or Asset Management AB Purchases 16,513 Shares of Meta Platforms, Inc. $META - MarketBeat
ARS Wealth Advisors Group LLC Boosts Stock Holdings in Meta Platforms, Inc. $META - MarketBeat
How Low Can META Really Go In A Market Crash? - Trefis
CHILTON INVESTMENT CO INC.'s Meta Platforms Inc(META) Holding History - GuruFocus
Meta Plunges on Jury Verdict. Here's What It Means for Investors - Yahoo Finance
Streetsboro couple sues Meta in son’s sextortion death - Cleveland 19 News
'We're having a moment'fear and denial in Silicon Valley over social media addiction trial - BBC
Unfortunate News for Meta Stock Investors - The Motley Fool
Meta Platforms Inc Class A Trade Ideas — BSESOF:FB2A - TradingView
About Facebook (META) - Investing.com
Will Meta Platforms, Inc. (META) hit Week of March 30 2026? Trading Odds & Predictions (Mar. 27, 2026) - Polymarket
Meta to Launch New AI Glasses Aimed at Prescription Wearers - Bloomberg.com
Meta promised it wouldn’t spy on you with its AI smart glasses. A lawsuit says humans are watching you, actually - Fortune
Meta’s New Executive Pay Plan Ties Nearly $1 Billion to Stock Performance - Equilar
Has Meta Platforms Become Addicted to AI Spending? - Yahoo Finance
Meta’s stock extends decline — and the pressure may not abate anytime soon - MarketWatch
Tech stocks suffer worst week in nearly a year, driven down by war worries, Meta legal woes - CNBC
Return on invested capital % of Meta Platforms Inc Class A – BSESOF:FB2A - TradingView
Meta set to decline over 12% for the week amid landmark legal losses, heavy AI bets (META:NASDAQ) - Seeking Alpha
Return on equity % of Meta Platforms Inc Class A – BSESOF:FB2A - TradingView
Return on assets % of Meta Platforms Inc Class A – BSESOF:FB2A - TradingView
Meta Set a $9 Trillion Target for the Stock. Then Came the Bad News. - Barron's
Meta, social media stocks continue slide Friday amid fallout from lawsuit losses - Yahoo Finance
Meta Stock: Mark Zuckerberg Won’t Be Deterred From AI Push, Shares Pay the Price - Barron's
Big Tech Just Got Hit—Why This Lawsuit Could Change Social Media Forever - MarketBeat
US Rep. Escobar calls on Meta to address data center impact in El Paso - El Paso Times
Meta stock price falls to nearly 1-year low: 3 reasons why the Facebook parent company is sinking in 2026 - fastcompany.com
Meta Platforms: Lean Into The Fear As P/Cash Drops To 10x (NASDAQ:META) - Seeking Alpha
META Deepens AI Strategy With New Arm CPU Initiative: What's Ahead? - theglobeandmail.com
Beijing's surprise intervention on Meta's Manus rattles tech founders, VCs eyeing 'China shedding' - CNBC
Meta's $10B Texas Data Center Investment - Gotrade
Meta Platforms Falls 3%: 3 Reasons the Platform Addiction Ruling Could Be Its Biggest Legal Threat Yet - Yahoo Finance
Meta, YouTube held liable in social media addiction trial - PRESS Insider
Meta funds seven gas plants to power biggest data center - mercurynews.com
Meta Platforms Inc Stock (META) Moved Down by 3.28% on Mar 27: Facts Behind the Movement - TradingKey
Meta Platforms (META) Slid on Concerns Over Aggressive AI Capital Expenditure Plans - Yahoo Finance
Utility Entergy says revised Meta data-center deal to deliver higher customer savings - Reuters
Meta Agrees to Fund Local Energy Infrastructure for Louisiana Data Center - WSJ
Can Meta’s $9 Trillion Valuation Target Be Hit By 2031? - Yahoo Finance
Meta Platforms Inc. (META): Billionaire David Abrams Trims Holding - Insider Monkey
No § 230 Immunity for Meta's AI-Generated Ads - Reason Magazine
Meta, Netflix, CrowdStrike And More On CNBC's 'Final Trades' - Benzinga
Meta boosts Texas AI data center spend to $10B (META:NASDAQ) - Seeking Alpha
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):